Metabolic dysfunction-associated steatohepatitis (MASH): Difference between revisions

No edit summary
No edit summary
Line 4: Line 4:


==Clinical Features==
==Clinical Features==
*Often asymptomatic or with mild [[RUQ pain|RUQ discomfort]]
*Signs of portal hypertension (e.g. [[ascites]]) if advanced fibrosis
*[[Hepatomegaly]]


==Differential Diagnosis==
==Differential Diagnosis==
*Cirrhosis
*[[Cirrhosis]]
*[[Hepatitis]]
*[[Hepatitis]]
*[[Budd-Chiari syndrome]]
*[[Budd-Chiari syndrome]]
*[[Hepatocellular carcinoma]]
*[[CHF]] (right heart failure]]
==Evaluation==
==Evaluation==
*LFT, CBC, CMP
*[[LFTs]], CBC, CMP
*Liver US
*[[RUQ US]]


==Management==
==Management==
*Treat complications of portal hypertension, if present


==Disposition==
==Disposition==


==See Also==
==See Also==
*[[Hepatomegaly]]


==External Links==
==External Links==

Revision as of 00:14, 27 January 2019

Background

  • Fatty liver disease due to causes other than excessive alcohol
  • Associated with insulin resistance and metabolic syndrome

Clinical Features

Differential Diagnosis

Evaluation

Management

  • Treat complications of portal hypertension, if present

Disposition

See Also

External Links

References